Overview

Cinnamon extract is derived from the inner bark of trees belonging to the genus Cinnamomum, with the two primary species used in supplements being Ceylon cinnamon (Cinnamomum verum) and Cassia cinnamon (Cinnamomum cassia). The distinction between these species is significant, as Cassia cinnamon contains substantially higher levels of coumarin, a compound that can be hepatotoxic in large amounts. Cinnamon has been used in traditional medicine systems across Asia and the Middle East for millennia, valued for its aromatic, antimicrobial, and digestive properties.

The key bioactive constituents of cinnamon extract include cinnamaldehyde, cinnamic acid, and type-A procyanidins. These compounds have demonstrated insulin-mimetic and insulin-sensitizing activity in laboratory studies, potentially through activation of insulin receptor kinase, inhibition of protein tyrosine phosphatase 1B, and enhancement of GLUT4 transporter translocation to the cell surface. Additional pharmacological activities include antioxidant, anti-inflammatory, and antimicrobial effects, with cinnamaldehyde showing particular potency against various bacterial and fungal species.

Clinical research on cinnamon extract for metabolic health has produced a heterogeneous body of evidence. Several meta-analyses have concluded that cinnamon supplementation may produce statistically significant but modest reductions in fasting blood glucose, total cholesterol, and triglycerides, particularly in individuals with type 2 diabetes. The variability in study results is partly attributable to differences in cinnamon species, extract standardization, dosing, and study population characteristics. Standardized aqueous extracts that concentrate the polyphenol fraction while reducing coumarin content are generally preferred for supplemental use.

Mechanism of Action

Type A Procyanidin Polymers — Insulin Mimetic Activity

Cinnamon extract (primarily from Cinnamomum cassia or C. burmannii) contains type A procyanidin polymers — doubly-linked catechin/epicatechin oligomers (trimer through pentamer) — as the principal bioactive insulin-potentiating compounds. These procyanidins directly activate the insulin receptor tyrosine kinase at the beta-subunit in a non-competitive manner, triggering autophosphorylation and downstream IRS-1/PI3K/Akt signaling independently of insulin binding. This insulin-mimetic activity persists in cell-free kinase assays, confirming a direct receptor interaction rather than insulin sensitization (PMID: 11506060).

GLUT4 & Glycogen Synthase Activation

Cinnamon polyphenols enhance GLUT4 translocation to the plasma membrane in adipocytes and myocytes through Akt-mediated AS160 phosphorylation, increasing glucose uptake by 3-5 fold in cell culture models. They also activate glycogen synthase through inhibition of glycogen synthase kinase-3beta (GSK-3beta), promoting glucose storage as glycogen in muscle and liver. Additionally, cinnamaldehyde (the major volatile constituent) inhibits protein tyrosine phosphatase 1B (PTP1B), the negative regulator of insulin receptor signaling, prolonging insulin signal duration (PMID: 19159947).

Cinnamaldehyde — TRPA1 & Metabolic Activation

Trans-cinnamaldehyde activates TRPA1 channels on sensory neurons and adipocytes, stimulating thermogenesis and energy expenditure through UCP1 induction in brown and beige adipocytes. TRPA1 activation also triggers GLP-1 release from enteroendocrine L-cells, enhancing postprandial insulin secretion and glucose tolerance. Cinnamaldehyde additionally inhibits alpha-glucosidase and alpha-amylase in the intestinal brush border, delaying carbohydrate digestion and reducing postprandial glucose excursions (PMID: 23680189).

Anti-Inflammatory & Antiglycation Effects

Cinnamon extract suppresses NF-kB activation by inhibiting IKKbeta phosphorylation, reducing COX-2, iNOS, and TNF-alpha expression. It also inhibits advanced glycation end-product (AGE) formation by trapping reactive dicarbonyl intermediates (methylglyoxal, glyoxal), protecting proteins from glycation-mediated cross-linking (PMID: 22327862).

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Cinnamon Extract

Common Side Effects

• Oral and GI irritation: burning sensation in the mouth, heartburn, and gastric discomfort, especially with Cassia (Cinnamomum cassia) varieties
• Allergic contact stomatitis and perioral dermatitis (cinnamon is a well-known contact allergen)
• Mild diarrhea or loose stools at higher extract doses
• Increased sweating and sensation of warmth (thermogenic effect)

Serious Adverse Effects

• Coumarin hepatotoxicity: Cassia cinnamon contains 1–5% coumarin by weight; chronic intake above 0.1 mg/kg/day coumarin (European Food Safety Authority tolerable daily intake) can cause dose-dependent liver damage including elevated ALT/AST and cholestatic hepatitis
• Hypoglycemia: particularly when combined with antidiabetic medications; symptoms include shakiness, confusion, diaphoresis
• Allergic reactions: rare anaphylaxis; more commonly urticaria, angioedema, and allergic contact dermatitis
• Anticoagulant effect: high coumarin intake has mild blood-thinning properties; risk of bleeding complications
• Cinnamaldehyde can cause esophageal irritation and ulceration if concentrated extract is taken without food

Contraindications

• Known cinnamon or cinnamaldehyde allergy
• Active liver disease or elevated liver enzymes
• Concurrent anticoagulant therapy (warfarin, heparin, DOACs) without medical supervision
• Oral ulcers or esophageal conditions (concentrated extracts)

Drug Interactions

• Antidiabetic medications (insulin, metformin, sulfonylureas): additive hypoglycemic effect; blood glucose monitoring essential
• Anticoagulants / antiplatelets (warfarin, aspirin, clopidogrel): coumarin content may potentiate bleeding; INR monitoring recommended with Cassia varieties
• Hepatotoxic drugs (statins, acetaminophen, ketoconazole): additive liver stress from coumarin; monitor LFTs
• CYP2A6 substrates: coumarin is metabolized by CYP2A6; potential competitive inhibition
• Antibiotics: in vitro antimicrobial activity may theoretically interact with antibiotic efficacy (clinical relevance unknown)

Population-Specific Considerations

• Pregnancy: Cassia cinnamon in large supplemental doses is not recommended due to coumarin content and potential uterotonic effects; Ceylon cinnamon (low coumarin) is safer but still limited data
• Children: culinary amounts are safe; concentrated extracts not studied
• Liver disease: choose Ceylon (Cinnamomum verum/zeylanicum) over Cassia—coumarin content is 250x lower
• Type 2 diabetes: promising adjunct but insufficient to replace medication; HbA1c reductions of 0.2–0.4% in meta-analyses
• Surgery: discontinue concentrated extracts at least 2 weeks prior due to anticoagulant potential

Pharmacokinetic Profile